الفهرس 
Classification of ObesityOnly 14 pages are availabe for public view
 |  | from | 118 |  |  |
| | | from | 118 | | |
Abstract
This study was conducted at The Gastrointestinal and Laparscopic Surgery Unit, General Surgery Department, Tanta University on 60 patients suffering from morbid obesity and completed at least 1 year follow-up after LMGB will be included in the study. The aim of the study was to analyze outcomes of (LMGB) performed for treatment of morbid obesity regarding weight loss,
improvement in co-morbid conditions, complications, quality of life (QOL) .
All patients who had LMGB for treatment of morbid obesity and
completed at least 1 year follow-up after surgery will be included in the study. Patients who had other weight reducing procedure and patients who had LMGB but did not complete at least 1 year follow-up after surgery were excluded from the study. The mean pre-operative weight was 144.40 ± 18.59 kg and the mean BMI was 53.29 ± 6.91 kg/m2 .The mean excess body weight was 77.07 ± 16.88. The mean waist/hip ratio was 0.85 ± 0.1. Obesity associated morbidities in this study included hypertension in 11 patients (18.3%), type 2 DM in 7 patients (11.7%), dyslipidaemia in 18 patients (30%), OSA in 19 patients (31.7%) and arthritis in 27 patients (45%), 22 patients (34.9%) with urinary symptoms and 22 patients (34.9%) with skin symptoms. Intra-operative complications were recorded in 10 patients (16.8%), short mesentry with multiple intestinal perforations converted to open surgery in 1 patient (1.7%). Early postoperative complications were in one male patient (1.7%) developed late staple line leakage the 5th postoperative day and was successfully treated conservatively. The mean EBWL % at 12 months was of 55.5 ± 10.18 kg. At 18 month follow-up, the EBWL% mean was 60.08 ± 12.29. At 24 months follow-up, the EBWL% mean was 64.96 ± 10.90. At 36 months follow-up, the mean was 72.71 ± 8.47. By the end of the study, the achieved weight reduction produced beneficial effects on the associated co-morbidities detected in our patients as follow: Resolution /Improvement of co-morbidities was 100 % for HTN , 100% for DM, 83% for Dyslipidemia 85%for degenerated joint disease ,94.7% for OSA. Late complications were encountered in 25 patients. Four patients developed gall stones, another patient was rehospitalized for severe hypoalbuminemia which converted laparscopically to RYGB after 1.5 year. Biliary reflux occurred in 8 patients , anemia in 4 patients and hypocalcaemia in 4 patients who were treated medically. No mortalities were recorded in this study.